MSH|^~\&|MIC|ARH|||201912061212||ORU^R01|4125077|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|36532^MIC|00027692^19:U0000337R^MIC^19:U337^36532|500.1000^U^Urine Culture^^^630-4||201912051400|201912050800|||||||201912051359|Urine^^^Midstream urine|||||||||MB|C||||
OBX|1|CE|500.1000^U^Urine Culture^^^630-4^O:KPNE|1.1|KPNE^Klebsiella pneumoniae||||||F|||201912051401
OBX|2|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.1|||||||F|||201912051401
OBX|3|ST|500.1000^U^Urine Culture^^^630-4^R:1000|1.1|>100|x 10*6 CFU/L||A|||F|||201912051401
OBR|2||00027692^19:U0000337R^MIC^19:U337^36532|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||201912051400|201912050800|||||||201912051359|Urine^^^Midstream urine|||||||||MB|C|U^1.1|||36532^MIC
OBX|1|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||S|||F|||201912051401
OBX|2|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||201912051401
OBX|3|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||201912051401
OBX|4|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||201912051401
OBX|5|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||201912051401
OBX|6|ST|300.100^TO^Tobramycin^^508-2^508-2|||||S|||F|||201912051401
OBX|7|ST|300.200^GM^Gentamicin^^267-5^267-5|||||R|||F|||201912051401
OBX|8|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||I|||F|||201912051401
OBX|9|ST|500.700^FD^Nitrofurantoin^^363-2^363-2|||||S|||F|||201912051401
OBX|10|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201912051401

MSH|^~\&|LAB|ARH|||201912061212||ORU^R01|4125079|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|36519^LAB|00027687^0512:C00003R^LAB^051219:C3^36519|500.1500^CP4^Chem 4 - Lytes^^^24326-1||201912051100|201912051102|||||||201912051102||||||||||LAB|F||||
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|160^^Y|mmol/L|135-145|H||A^S|C|||201912051129
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|2.5^^Y|mmol/L|3.5-5.0|LL||A^S|C|||201912051129
NTE|1||*CRITICAL VALUE
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|110^^Y|mmol/L|98-108|H||A^S|C|||201912051129
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|25^^Y|mmol/L|20-30|N||A^S|C|||201912051129
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|25^^Y|mmol/L|3-16|H||A^S|C|||201912051129
OBR|2|36519^LAB|00027687^0512:C00003R^LAB^051219:C3^36519|500.3900^MG^Magnesium^^2601-3^2601-3||201912051100|201912051102|||||||201912051102||||||||||LAB|F||||
OBX|1|ST|500.3900^MG^Magnesium^^2601-3^2601-3|1|1.0^^Y|mmol/L|0.7-1.2|N||A^S|C|||201912051129
NTE|1||In management of Eclampsia, the reference range is not
NTE|2||transferable as a therapeutic range.
OBR|3|36519^LAB|00027687^0512:C00003R^LAB^051219:C3^36519|520.4200^IRON^Iron Studies Profile^^^50190-8||201912051100|201912051102|||||||201912051102||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|30^^Y|umol/L|9-30|N||A^S|C|||201912051129
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|40^^Y|umol/L|45-70|L||A^S|C|||201912051129
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.75^^Y||0.15-0.55|H||A^S|C|||201912051129
NTE|1||Markedly elevated transferrin saturation.  Follow up and
NTE|2||management as per BCMA/MSP Iron Overload protocol.

MSH|^~\&|LAB|ARH|||201912061212||ORU^R01|4125080|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|36520^LAB|00027687^0512:CS00002R^LAB^051219:CS2^36520|523.1895^HIV^HIV -Nominal Reporting^^^75666-8||201912051100|201912051102|||||||201912051102||||||||||LAB|F||||
OBX|1|ST|523.19061^HIV EIA4G^HIV 1 and 2 Ab/Ag EIA Screen^HIVCC^XXX-2887^XXX-2887|1|Nonreactive^^N|||N||A^S|C|||201912051138

MSH|^~\&|LAB|ARH|||201912061212||ORU^R01|4125081|D|2.3|||AL|NE
PID|1||AB00008388|AB8306|LABTEST^UCI^ROSE||19851010|F||||||||||AB000737/19|9874794993
OBR|1|36521^LAB|00027687^0512:CU00001R^LAB^051219:CU1^36521|560.6500^UNA24^Urine Sodium, 24hr Group^^^2956-1||201912051100|201912051102|||||||201912051102||||||||||LAB|F||||
OBX|1|ST|560.6700^UNA24 R^Urine Sodium 24hr Result^^2956-1^2956-1|1|50^^Y|mmol/d|40-220|N||A^S|C|||201912051128
OBX|2|ST|560.8300^UCRE24 R^Urine Creatinine 24hr Result^^14684-5^14684-5|1|10.0^^Y|mmol/d|5.0-16.0|N||A^S|C|||201912051128
OBX|3|ST|570.0000^UVOL24^Urine 24hr Volume (mls)^^3167-4^3167-4|1|1000^^Y|mL||N||A^S|C|||201912051128
OBX|4|ST|570.0100^UTIMHR^Urine Time (hr)^^13362-9^13362-9|1|24^^Y|h||N||A^S|C|||201912051128
NTE|1||Collected and reported for collection period specified.
NTE|2||Reference interval based on a 24 hour urine collection.